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A QUALITATIVE APPROACH: WHO IS UNDERGOING




Background: Although total joint replacement of the hip and
knee (TJA) is a highly effective treatment for advanced arthri-
tis, significant differences in TJA rates have been observed by
gender, race/ethnicity, and socioeconomic status (SES). Poten-
tial explanations include the effects of socio-demographics (e.g.
individuals’ characteristics and knowledge of TJA), and health
beliefs (e.g. risk perceptions and trust), lack of community and
personal/family resources (e.g. health insurance, living circum-
stances and social support), and preferences for treatment.
Methods: A thorough review of the literature was performed to
assess the role of patients’ perspectives regarding TJA on use
of this procedure.
Results: Qualitative and quantitative research shows that pa-
tients’ willingness to consider TJA as a treatment option varies
by gender, race/ethnicity, and socioeconomic status (SES) as
a result of systematic differences in individuals’ knowledge and
beliefs about TJA across groups. In general, individuals with low
SES and minorities view TJA less favorably than their wealth-
ier, White counterparts, possibly explaining, in part, observed
disparity in rates of use of TJA among these groups. Patient
information needs regarding TJA vary significantly and possi-
bly also systematically by gender and race/ethnicity. Currently
available information materials may not address the concerns
of many individuals contemplating TJA, posing an additional po-
tential barrier to surgery. Early work also suggests that patients’
expectations and self-efficacy are important potential predictors
of post-operative outcome in TJA. In a prospective cohort of
individuals with advanced hip/knee OA, willingness to consider
TJA was the strongest predictor of time to receipt of first TJA
(HR=3.36, p<0.0001). Additional predictors were: higher (worse)
baseline WOMAC scores (Hazard Ratio, HR=1.28 per 10-unit in-
crease, p<0.0001), age (HR =1.68 for 61-80 years versus 55-60
years, p=0.003), fewer comorbidities (HR for 2+ versus 0 condi-
tions = 0.70, p=0.023) and better health (HR = 1.07 per 1-unit
increase in SF-36 General Health score, p <0.0001).
Conclusion: Willingness to consider TJA is the strongest pre-
dictor of time to receipt of first TJA. Given that willingness is
largely explained by perceptions of the indications for and risks
associated with TJA, this finding supports the need for targeted,
culturally sensitive knowledge dissemination strategies to im-
prove the knowledge and beliefs of people with hip/knee arthritis
about TJA. Such strategies have the potential to reduce both
disparities in rates of use of TJA as well as to improve outcomes
in those who choose to undergo this procedure.
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TOTAL ARTICULAR REPLACEMENT: AN OUTCOME
MEASURE FOR EVALUATION DMOADS
Maxime Dougados
Disease Modifying OsteoArthritis Drugs (DMOADs) are expected
to interfere with the natural history of the disease by preventing
and/or reducing the handicap due to the anatomical (in par-
ticular cartilage) breakdown of the osteoarthritic process. Such
objective can be reached by evaluating these 2∼domains (e.g.
handicap on one hand and structure on the other hand). How-
ever, both domains are criticized [the tools evaluating the level
of handicap are not specific and, therefore, might be influenced
by therapies (e.g. anti-depressive agents) which are far from the
osteoarthritic process; on the other hand, the clinical relevance
of small changes in the structural parameters is not yet well es-
tablished]. Therefore, a composite index merging the information
from these 2∼domains (handicap and structure) might represent
an appropriate alternative. The requirement to surgery has been
proposed as such alternative since this decision is based on the
level of both symptoms and structural deterioration.
Preliminary data suggests that such outcome is simple, valid
and sensitive at least when choosing hip OA as the target joint.
The main criticisms of the choice of such outcome variable is
its poor inter-country reliability and its supposed lack of face
validity. Such criticisms prompted both OARSI and OMERACT to
propose as an outcome measure the virtual surgery, i.e., a score
combining the information from different domains above which a
surgery should be considered.
Therefore, the current proposal when conducting clinical trials
is to collect the information allowing the calculation of the per-
centage of patients undergoing surgery and/or requiring surgery.
Such information can be collected during the evaluated treatment
period but also during the period following such treatment period
in order to evaluate the potential carry-over effect of the study
drug. Preliminary data have been observed with both diacerein
and glucosamine sulfate.
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CYTOKINES, PROTEASES AND GROWTH FACTORS IN
THE PATHOPHYSIOLOGY OF OSTEOARTHRITIS: WHAT
ARE THEIR LEVELS OF GUILT?
Johanne Martel-Pelletier
The morphological changes observed in osteoarthritis (OA) in-
clude alterations in the cartilage and subchondral bone, and
synovial inflammation. These changes are believed to be related
to a complex network of biochemical factors, which lead to the
breakdown of macromolecules in the articular tissue. It appears
that there is a movement of factors and cytokines from the differ-
ent joint tissues to the cartilage. There is now evidence of global
cross-talk among the above tissues.
Current knowledge points to an important involvement of the met-
alloprotease (MMP) class in the OA process, and collagenase-3
or MMP-13 was demonstrated to play a major role in cartilage
degeneration. It is suggested that another enzyme, aggrecanase-
2 or ADAMTS-5, is responsible for the proteolysis of cartilage
aggrecan.
Growth factors are among the factors that may be involved in car-
tilage regeneration. Among these, TGF-β and IGF-1 have been
studied extensively with respect to their expression and roles in
OA. Recently, others such as the BMPs have received more at-
tention as to their implication in OA. BMPs are known for their role
in the maintenance and repair of bone, cartilage and other tissues
in adults. Interestingly, BMP activity/availability can be controlled
by specific antagonists. There have been demonstrations of a
role for some BMP antagonists in OA. Importantly, in OA carti-
lage, a differential topographical distribution and regulation was
found between some members of the BMP antagonists in OA
chondrocytes, suggesting their appearance at different stages
during the OA process and/or that they play different roles.
Even if cartilage destruction characterizes the OA condition,
synovial inflammation is of fundamental importance in the pro-
gression of cartilage lesions in this disease. Findings point to the
importance of proinflammatory cytokines in the catabolic process
in OA, the IL-1β being the prime cytokine involved.
Recent work also suggests that very early in the OA process, bio-
logical and morphological disturbances occur at the subchondral
bone, and that alterations in this tissue are responsible for early
pathological changes in cartilage. Its key role in the initiation
and/or progression of OA will be discussed.
